Global Top 4 Companies Accounted for 81% of total Phenylketonuria (PKU) market (QYResearch, 2021) (Internet Services - Other Internet Services)

Item ID 3873956 in Category: Internet Services - Other Internet Services

Global Top 4 Companies Accounted for 81% of total Phenylketonuria (PKU) market (QYResearch, 2021)
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. This report mainly focuses on the treatment for PKU. The global key manufacturers of Phenylketonuria (PKU) include Biomarin, Mead Johnson, Abbott, Nutricia, Dr. Schär, etc. In 2020, the global top four players had a share approximately 81.0% in terms of revenue. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com

Target Prov.: All Provinces Target City : All Cities Last Update : May 16, 2024 2:42 AM Number of Views: 28	Item Owner : David Contact Email: (None) Contact Phone: (None)

Friendly reminder: Click here to read some tips.

2024-06-12 (0.404 sec)